High-Throughput Radiometric CYP2C19 Inhibition Assay Using Tritiated (S)-Mephenytoin
Annalise Di Marco, Antonella Cellucci, Ashok Chaudhary et al. · Drug Metabolism and Disposition · 2007
Cited by 15 works. doi:10.1124/dmd.107.016345
Authors
References
- Arene oxides and the NIH shift: The metabolism, toxicity and carcinogenicity of aromatic compounds
- The Human Hepatic Cytochromes P450 Involved in Drug Metabolism
- Use of In Vitro and In Vivo Data to Estimate the Likelihood of Metabolic Pharmacokinetic Interactions
- IN VITRO AND IN VIVO DRUG INTERACTIONS INVOLVING HUMAN CYP3A
- Clinical Significance of the Cytochrome P450 2C19 Genetic Polymorphism
- [1] Statistical analysis of radioligand assay data
- Inhibition and Induction of Cytochrome P450 and the Clinical Implications
- Clinical relevance of genetic polymorphisms in the human CYP2C subfamily
- VALIDATED ASSAYS FOR HUMAN CYTOCHROME P450 ACTIVITIES
- Effect of common organic solvents on in vitro cytochrome P450-mediated metabolic activities in human liver microsomes.